Edition:
India

Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

20.11USD
8:06pm IST
Change (% chg)

$0.48 (+2.45%)
Prev Close
$19.63
Open
$19.75
Day's High
$20.11
Day's Low
$19.73
Volume
19,922
Avg. Vol
287,051
52-wk High
$25.20
52-wk Low
$8.36

Select another date:

Fri, Apr 27 2018

BRIEF-FDA Grants Breakthrough Therapy Designation To Omeros' Masp-2 Inhibitor Oms721

* FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION TO OMEROS’ MASP-2 INHIBITOR OMS721 FOR THE TREATMENT OF HIGH-RISK HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

BRIEF-Omeros Announces Amendment Of Credit Facility

* AMENDED ITS EXISTING CREDIT FACILITY WITH CERTAIN AFFILIATES OF CRG LP

BRIEF-Omeros Q4 Loss Per Share $0.34

* Q4 REVENUE $13.8 MILLION Source text for Eikon: Further company coverage:

Select another date: